Please Wait
Applying Filters...
menu
    • menu
    Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

    Data Compilation
    #PharmaFlow

    Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

    Stock Recap
    #PipelineProspector

    Menu

    Rifampin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 205Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    31/10/2025 CKD Bio Corporation
    South Korea
    		 Chong Kun Dang Bio Co., Ltd. 20090130-103-F-36-01 Rifampicin 2009-01-30 Chong Kun Dang Bio Co., Ltd._x000D_ South Korea 454,486 Biblock 16 Complex, Moknae-dong, Danwon-gu, Ansan-si, Gyeonggi-do (425-100) (368-3 Chungjeong-ro 3-ga, Seodaemun-gu, Seoul (120-756))
    31/10/2025 Lupin Ltd
    India
    		 Masung LS Co., Ltd. 20091027-103-F-48-03 Rifampicin 2009-10-27 Lupin Limited, India India, T-142, MIDC, Tarapur, Via Boisar, Maharashtra 401 506